JP2024512986A5 - - Google Patents

Info

Publication number
JP2024512986A5
JP2024512986A5 JP2023559766A JP2023559766A JP2024512986A5 JP 2024512986 A5 JP2024512986 A5 JP 2024512986A5 JP 2023559766 A JP2023559766 A JP 2023559766A JP 2023559766 A JP2023559766 A JP 2023559766A JP 2024512986 A5 JP2024512986 A5 JP 2024512986A5
Authority
JP
Japan
Prior art keywords
alkyl
ring atoms
group
alkenyl
heteroatoms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023559766A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024512986A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2022/058402 external-priority patent/WO2022207699A1/en
Publication of JP2024512986A publication Critical patent/JP2024512986A/ja
Publication of JP2024512986A5 publication Critical patent/JP2024512986A5/ja
Pending legal-status Critical Current

Links

JP2023559766A 2021-03-30 2022-03-30 改良された物理化学的特性および薬理学的特性を有する酵素トリガー自己反応性リンカー Pending JP2024512986A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202163167915P 2021-03-30 2021-03-30
EP21305405.9 2021-03-30
EP21305405 2021-03-30
US63/167,915 2021-03-30
PCT/EP2022/058402 WO2022207699A1 (en) 2021-03-30 2022-03-30 Enzyme-triggered self-reacting linker having improved physicochemical and pharmacological properties

Publications (2)

Publication Number Publication Date
JP2024512986A JP2024512986A (ja) 2024-03-21
JP2024512986A5 true JP2024512986A5 (cg-RX-API-DMAC10.html) 2025-04-02

Family

ID=81580241

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023559766A Pending JP2024512986A (ja) 2021-03-30 2022-03-30 改良された物理化学的特性および薬理学的特性を有する酵素トリガー自己反応性リンカー

Country Status (10)

Country Link
US (1) US20240216525A1 (cg-RX-API-DMAC10.html)
EP (1) EP4313157A1 (cg-RX-API-DMAC10.html)
JP (1) JP2024512986A (cg-RX-API-DMAC10.html)
KR (1) KR20230165288A (cg-RX-API-DMAC10.html)
AU (1) AU2022248565A1 (cg-RX-API-DMAC10.html)
BR (1) BR112023019495A2 (cg-RX-API-DMAC10.html)
CA (1) CA3215279A1 (cg-RX-API-DMAC10.html)
IL (1) IL306050A (cg-RX-API-DMAC10.html)
MX (1) MX2023011630A (cg-RX-API-DMAC10.html)
WO (1) WO2022207699A1 (cg-RX-API-DMAC10.html)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12605459B2 (en) 2020-07-13 2026-04-21 Regeneron Pharmaceuticals, Inc. Protein-drug conjugates comprising camptothecin analogs and methods of use thereof
MX2024008640A (es) * 2022-01-12 2024-07-24 Regeneron Pharma Analogos de camptotecina conjugados a un residuo de glutamina en una proteina y su uso.
AU2023231442B2 (en) * 2022-03-11 2026-07-02 Mablink Bioscience Antibody-drug conjugates and their uses
JP2026504840A (ja) * 2023-01-11 2026-02-10 ジェンマブ エー/エス リンカー、薬物リンカー、およびそれらの複合体、ならびにそれらを使用する方法
WO2024222841A1 (zh) * 2023-04-27 2024-10-31 石药集团巨石生物制药有限公司 一种抗体药物偶联物
AU2024263367A1 (en) * 2023-04-27 2025-11-13 CSPC Megalith Biopharmaceutical Co., Ltd. Antibody-drug conjugate
EP4512427A1 (en) 2023-08-25 2025-02-26 Mablink Bioscience Antibody-drug conjugates based on molecular glue degraders and uses thereof
EP4534102A1 (en) 2023-10-02 2025-04-09 Eli Lilly and Company Antibody drug conjugate (adc) targeting nectin 4 and comprising an exatecan payload
EP4534101A1 (en) 2023-10-02 2025-04-09 Eli Lilly and Company Antibody drug conjugate (adc) targeting nectin 4 and comprising an exatecan payload
FR3155708A1 (fr) * 2023-11-27 2025-05-30 Skymab Biotherapeutics Conjugue anticorps-medicament et ses utilisations
FR3155709A1 (fr) * 2023-11-27 2025-05-30 Skymab Biotherapeutics Conjugue anticorps-medicament et ses utilisations
EP4566631A1 (en) 2023-12-06 2025-06-11 Heidelberg Pharma Research GmbH New antibody drug conjugate as well as methods of production and uses thereof
WO2025230926A1 (en) * 2024-04-29 2025-11-06 Obi Pharma, Inc. Improved linker-payloads for antibody conjugation, pharmaceutical compositions and applications thereof
WO2026076215A1 (en) * 2024-10-03 2026-04-09 Solve Therapeutics, Inc. Conjugates and uses thereof
WO2026085106A1 (en) * 2024-10-15 2026-04-23 Solve Therapeutics, Inc. Conjugates and uses thereof
WO2026086855A1 (zh) * 2024-10-25 2026-04-30 石药集团巨石生物制药有限公司 一种靶向cdcp1的抗体药物偶联物及其用途
WO2026112064A1 (en) * 2024-11-20 2026-05-28 Solve Therapeutics, Inc. Conjugates of anti-5t4 antibodies with drugs and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2775976B1 (fr) * 1998-03-10 2000-06-02 Fabre Pierre Dermo Cosmetique Composition pharmaceutique ou cosmetique contenant un precurseur d'actif hydrolysable par la glucocerebrosidase
FR2960153B1 (fr) 2010-05-20 2012-08-17 Centre Nat Rech Scient Nouveaux bras autoreactifs et prodrogues les comprenant
US20170014524A1 (en) * 2015-07-15 2017-01-19 The California Institute For Biomedical Research Auristatin-antibody conjugates and uses thereof
CN107847605B (zh) 2015-11-25 2021-12-24 乐高化学生物科学股份有限公司 包含分支接头的抗体-药物缀合物及其相关方法
EP3700577A1 (en) * 2017-10-23 2020-09-02 Mablink Bioscience Ligand-drug-conjugate comprising a single molecular weight polysarcosine

Similar Documents

Publication Publication Date Title
JP7644173B2 (ja) 単一分子量ポリサルコシンを含むリガンド-薬物-複合体
IL306050A (en) Enzyme-triggered self-reacting linker having improved physicochemical and pharmacological properties
JP2024042054A (ja) カンプトテシンペプチドコンジュゲート
JP2024099041A5 (cg-RX-API-DMAC10.html)
DK2678037T3 (en) Branched linker for protein pharmaceutical conjugates
JP2023529415A (ja) 高安定性の親水性結合ユニットを有するカンプトテシン類薬物及びその複合体
JP2023514275A (ja) 標的化された送達の用途のための線維芽細胞活性化タンパク質リガンド
JP7814303B2 (ja) 内部移行した生物学的に活性な化合物の結合体からの選択的な薬物放出
JP2025510629A (ja) カンプトテシンコンジュゲート
JP2023530128A (ja) 細胞結合分子とカンプトテシン類縁体との共役体
JP2021510696A5 (cg-RX-API-DMAC10.html)
JP2021527040A (ja) カンプトテシンコンジュゲート
JP2019502650A5 (ja) 抗ErbB2抗体−薬物コンジュゲート及びその組成物、そのための調製方法、並びにその使用
JP2011102329A (ja) ヘテロ二官能性重合体生物複合体
JP7750837B2 (ja) 反応性コンジュゲート
JP2023010733A (ja) γ-アマニチンの誘導体
JP2022126826A (ja) ヘテロアリールスルホンをベースとするコンジュゲーションハンドル、これらの調製のための方法、および抗体薬物コンジュゲートの合成におけるこれらの使用
CN104884056A (zh) 用于制备缀合物的化合物和方法
JP2017501128A (ja) ヒドラジニル−ピロロ化合物及び複合体を生成するための方法
CN112839683A (zh) 含有标记部-抗人抗体Fab片段复合物的药物组合物
JP2024529466A5 (cg-RX-API-DMAC10.html)
CN120957758A (zh) 大环化合物及其制备方法和用途
JP6585650B2 (ja) 細胞毒性剤と細胞結合受容体との共役体
JP2023159139A (ja) 新規な連結体及び生体分子と薬物との特異的共役におけるその使用
KR960701667A (ko) 2작용기성 킬레이트제, 그 테크네튬 및 레늄 착물과 이들의 제조방법 및 이들 화합물을 함유하는 방사성 약물